Prescription Labs Inc dba Greenpark

FDA Regulatory Profile

Prescription Labs Inc dba Greenpark appears in FDA public data with 1 recall, 0 510(k) clearances, 2 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0804-2021, Class II) was initiated on August 18, 2021.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
2
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0804-2021Class IISpironolactone Ophthalmic Solution 0.005 mg/mL, 15 mL bottles, Rx only, Greenpark Compounding PharmaAugust 18, 2021